2019 GSR Annual Meeting
May 31 - June 2, 2019
Ritz-Carlton, Reynols Plantation

Guest Speakers

Rohit Aggarwal, MD, MS

Dr. Aggarwal is an Associate Professor of Medicine at University of Pittsburgh, Rheumatology Division. He is also Medical Director of Arthritis and Autoimmunity Center as well as Co-Director of Myosits Center at University of Pittsburgh. His research interest includes clinical and translation research in myositis, anti-synthetase syndrome and association interstital lung disease. He specifically interested in development of clinical outcomes in myositis and clinicopathological correlation of serological biomarkers like serum autoantibodies in myositis.

Dr. Aggarwal’s research interests in myopathies including polymyositis, dermatomyositis, and inclusion body myositis. He is also interested in autoimmune or connective tissue disease related interstitial lung disease or pulmonary fibrosis.

Dr. Aggarwal’s clinical interest include the following: General rheumatology, rheumatoid arthritis, lupus, Sjogren syndrome, vasculitis, psoriatic arthritis, sarcoidosis, Myositis, Polymyositis, Dermatomyositis, Inclusion body myositis, systemic sclerosis, mixed connective tissue disease. Also autoimmune or connective tissue disease related interstitial lung disease or pulmonary fibrosis.

  Jeffrey R. Curtis, MD, MS, MPH

Dr. Jeffrey Curtis is a Professor of Medicine in the Division of Clinical Immunology and Rheumatology at the University of Alabama at Birmingham (UAB). He is the Co-Director of the UAB Center for Education and Research on Therapeutics (CERTs) of Musculoskeletal Disorders, which has a major emphasis on evaluating the safety and comparative effectiveness of medications for rheumatic diseases. Additionally, as the Director of the UAB Arthritis Clinical Intervention Program, he leads the clinical trials unit for the rheumatology division at UAB, with a particular focus on rheumatoid arthritis (RA) and psoriatic arthritis (PsA). He is the Co-Director of the UAB Pharmacoepidemiology and Pharmacoeconomics Research (PEER) Unit. PEER uses multiple large data sources to study comparative effectiveness questions across multiple chronic diseases. These data sources include national administrative data from Medicare and commercial health plans, electronic health record data, and large registries. He has been awarded the William J. Koopman Endowed Professorship in Rheumatology and Immunology.

Dr. Curtis received a Medical Degree (MD) and a Master of Public Health (MPH) degree from Oregon Health & Sciences University in Portland, OR. He subsequently completed a residency in internal medicine at Oregon Health & Science University and a fellowship in rheumatology at UAB. He received his Master of Science (MS) degree in epidemiology at the Harvard School of Public Health. His subsequent work in Clinical Informatics was done at Stanford University. He is board-certified in rheumatology.

The evaluation of the efficacy, comparative effectiveness, and safety of the medications used to treat rheumatoid arthritis and spondyloarthritis are among Dr. Curtis?s research interests. He served on the Core Expert Panel for the ACR?s 2008 and 2012 Recommendations for the Use of Nonbiologic and Biologic Disease Modifying Antirheumatic Drugs in RA and is part of the forthcoming 2015 ACR Recommendations. He was the Deputy Director for a collaborative project between the FDA, the Agency for Healthcare Research and Quality (AHRQ), and a number of academic centers studying the safety of biologic agents using multiple, pooled national data sources. He is the Co-PI of the PCORI-funded Patient Powered Research Network focused on RA, psoriasis, and PsA.

Dr. Curtis also studies risk factors for and outcomes of osteoporosis. He was a member of the ACR's task force to update recommendations for the management of glucocorticoid induced osteoporosis (GIOP). He also served on the ASBMR Task Force on Atypical Subtrochanteric and Diaphyseal Fractures.

Dr. Curtis is a member of the American College of Rheumatology (ACR), the International Society for Pharmacoepidemiology (ISPE), and the American Society of Bone and Mineral Research (ASBMR). He has authored more than 200 peer-reviewed articles and book chapters. He is on the editorial board for Arthritis & Rheumatism, Pharmacoepidemiology and Drug Safety (PDS) and Arthritis Care and Research (AC&R).

Orlando G. Florete, Jr., MD

Dr. Orlando Florete Jr. is a remarkable pain management expert with 17 years of expertise in various areas of anesthesiology. He is the Medical Director and Interventional Pain Management Specialist with the Institute of Pain Management and Director of Florida Institute of Medical Research. Additionally, Dr. Orlando Florete Jr. is affiliated with the Baptist Medical Center, Jackson Memorial Hospital, and St. Luke’s Medical Center. He is a widely acclaimed speaker on treatment algorithms for pain management on a national and international scale. Furthermore, Dr. Orlando Florete Jr. is the author of numerous book chapters, journal articles, teaching materials, and abstracts. In addition to his professional endeavors, he is consistently providing for those in need through donations to a variety of catholic charities.

Dr. Orlando Florete Jr., obtained his Medical Degree in 1981 from Cebu Institute of Medicine, in the Philippines. He continued to explore his passion for medicine with an internship and residency at the University of the Philippines. Dr. Orlando Florete Jr. advanced his training with a fellowship in cardiology at the University of Philippines, fellowship in critical care medicine from the University of Florida, and residency in anesthesiology from the University of Florida. He is Board Certified in Pain Management and Anesthesiology with pain management training at the University of Virginia and University of Kentucky. He is also the president and co-founder of the American Medical Marijuana Physicians Association. Over the course of his career, he was awarded the Community Service Award and Winthrop Stearns Scholarship Award from the Department of Anesthesiology at the University of Florida College of Medicine. He attributes his success to hard work and love for the profession.

Dr. Orlando Florete Jr. has recently earned inclusion in the prestigious publication The Leading Physicians of The World as a result of his exceptional work in the field of pain management and anesthesiology. The Leading Physicians Of The World is published by the International Association of Healthcare Professionals, the national authority in career and business development. In addition, Dr. Orlando Florete Jr. is a member of the American Association of Pain Management, American Medical Association, Florida Society of International Pain Medicine, American Society of Interventional Pain Physicians, Florida Medical Association, Duval County Medical Society, and American Society of Anesthesia. Moreover, he is a lifetime member of the Winthrop Stearns Fellows and Scholars Association. In his free time, he enjoys boating on his yacht, running, traveling, and reading.

Sarah Morgan, MD, MS, RD, FADA, FACP, CCD

Dr. Morgan is a registered/licensed dietitian and an internist. Dr. Morgan's research program has been focused on methotrexate and folic acid metabolism in patients with rheumatoid arthritis. Her work with Dr. Joseph E Baggott and members of the Division of Clinical Immunology and Rheumatology (Drs. Graciela Alarcon, Dr. William Koopman, Dr. S Louis Bridges, and Dr. Laura Hughes) have established the folic acid supplementation during low dose methotrexate therapy for rheumatoid arthritis lowers toxicity without affecting efficacy. Drs Morgan and Baggott have also studied purine metabolism and methotrexate therapy in rat adjuvant arthritis and participate in trials related to methotrexate pharmacogenetics. Dr. Morgan and Dr. Baggott have also investigated the effects of a medical food on osteoarthritis. As the Medical Director of the UAB Osteoporosis Prevention and Treatment Clinic, Dr. Morgan has an interest in bone densitometry and clinical trials related to osteoporosis. She has been a president of the International Society for Clinical Densitometry. She currently serves as a faculty member related to bone densitometry and vertebral fracture recognition. periarticular tissue responses to different therapies in inflammatory arthritis.